Life Technologies Unveils One-Day Genome Sequencer Product; Shares Jump 8% to Our $47 Fair Value Estimate
publication date: Jan 10, 2012
Life Technologies announced that it has begun accepting orders for a product named the Ion Proton Sequencer that could sequence a person's entire genome in just one day (more expensive, competing machines can take weeks or longer to do the same procedure). We had been expecting valuation upside from the firm, and its shares have now converged to our $47 fair value estimate.
This page is available to subscribers only. To gain access to members only content (including this research piece), click here to subscribe. With a subscription, you'll have access to all of our premium commentary, equity reports, dividend reports and Best Ideas Newsletter and Dividend Growth Newsletter, as well as receive discounts on all of our modeling tools and products. Financial advisers and institutional investors have even more to choose from!